This is a news story, published by Sky News, that relates primarily to Pascal Soriot news.
For more Pascal Soriot news, you can click here:
more Pascal Soriot newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Sky News, you can click here:
more news from Sky NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
other European healthcare providers. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cure patients news, breast cancer treatments news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
NHSSky News
•82% Informative
The National Institute for Health and Care Excellence (NICE) decided in March this year that patients should be denied access to Enhertu because it said the drug did not provide value for money.
Sir Pascal Soriot said he was disappointed at the decision - which is estimated to have affected at least 1,000 patients to date.
He said he had raised the issue at "every opportunity" with ministers.
AstraZeneca committed to launching 20 new molecular entities (medicines to be submitted for clinical trials) by 2030 .
These include treatments for types of cancer, obesity, kidney disease and heart disease.
'Combination therapies' - where more that one medicine is used in a treatment regimen - are revolutionising the future of healthcare.
VR Score
86
Informative language
86
Neutral language
82
Article tone
informal
Language
English
Language complexity
52
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links